Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03696368 · ClinicalTrials.gov registry record
The Hoosier Moms Cohort
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 411
- Enrollment target
NCT03696368 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 411 participants.
The verdict
NCT03696368 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 411 participants
- Enrollment target
Study Summary
The Hoosier Moms Cohort (HMC) study's goal is to better understand the pathophysiology underlying the development of gestational diabetes mellitus (GDM) in pregnant women and its transition to Type 2 diabetes mellitus in mothers and their exposed children. The HMC study wants to determine what biomarkers (genetic, blood based and behavioral/interventional) can be identified in pregnant women affected with GDM and how those biomarkers can be used to impact preventative care.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 411 participants |
| Start Date | 2019-01-04 |
| Est. Completion | 2023-01-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03696368
The ClinicalTrials.gov registry entry for NCT03696368 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 411 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03696368 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03696368 about?
NCT03696368 is a clinical study titled "The Hoosier Moms Cohort". The Hoosier Moms Cohort (HMC) study's goal is to better understand the pathophysiology underlying the development of gestational diabetes mellitus (GDM) in pregnant women and its transition to Type 2 diabetes mellitus in mothers and their exposed children. The HMC study wants to determine what biom...
What is the current status of trial NCT03696368?
This trial is currently completed. The enrollment target is 411 participants. The study started on 2019-01-04. Estimated completion is 2023-01-15.
Who is sponsoring clinical trial NCT03696368?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.